EP3332789
Kladribín meðferðaráform til meðhöndlunar á heila- og mænusiggi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
20.12.2005EP published:
6.4.2022EP application number:
18151634.5
EP translation filed:
3.6.2022Grant published:
15.7.2022EPO information:
European Patent Register
Max expiry date:
19.12.2025Expiry date:
19.12.2025
Title in English:
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSISLanguage of the patent:
English
Timeline
Today
20.12.2005EP application
6.4.2022EP Publication
3.6.2022Translation submitted
15.7.2022Registration published
19.12.2025Expires
Owner
Name:
Merck Serono SAAddress:
Centre Industriel, 1267 Coinsins, Vaud, CH
Inventor
Name:
De Luca, GiampieroAddress:
1231 Conches, CH
Name:
Ythier, AmaudAddress:
1239 Collex-Bossy Geneva, CH
Name:
Munafo, AlainAddress:
1182 Gilly, CH
Name:
Lopez-Bresnahan, MariaAddress:
Lincoln, MA, 01773, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
638669 PDate:
22.12.2004Country:
US
Number:
04106909Date:
22.12.2004Country:
EP
Classification
Categories:
A61K 31/7076, A61K 38/21, A61P 25/00, A61P 25/28
Annual fees
Number
Paid
Expires
Payer
Number: 18
Paid: 9.11.2022
Expires: 19.12.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 11.12.2023
Expires: 19.12.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 5.11.2024
Expires: 19.12.2025
Payer: Árnason Faktor ehf.